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AMPK directly inhibits NDPK through a
phosphoserine switch to maintain cellular
homeostasis
Rob U. Onyenwokea, Lawrence J. Forsberga, Lucy Liua, Tyisha Williamsa, Oscar Alzateb,
and Jay E. Brenmana,b
a

Neuroscience Center and bDepartment of Cell and Developmental Biology, University of North Carolina School of
Medicine, Chapel Hill, NC 27599

ABSTRACT AMP-activated protein kinase (AMPK) is a key energy sensor that regulates metabolism to maintain cellular energy balance. AMPK activation has also been proposed to
mimic benefits of caloric restriction and exercise. Therefore, identifying downstream AMPK
targets could elucidate new mechanisms for maintaining cellular energy homeostasis. We
identified the phosphotransferase nucleoside diphosphate kinase (NDPK), which maintains
pools of nucleotides, as a direct AMPK target through the use of two-dimensional differential
in-gel electrophoresis. Furthermore, we mapped the AMPK/NDPK phosphorylation site (serine 120) as a functionally potent enzymatic “off switch” both in vivo and in vitro. Because ATP
is usually the most abundant cellular nucleotide, NDPK would normally consume ATP, whereas AMPK would inhibit NDPK to conserve energy. It is intriguing that serine 120 is mutated
in advanced neuroblastoma, which suggests a mechanism by which NDPK in neuroblastoma
can no longer be inhibited by AMPK-mediated phosphorylation. This novel placement of
AMPK upstream and directly regulating NDPK activity has widespread implications for cellular energy/nucleotide balance, and we demonstrate in vivo that increased NDPK activity
leads to susceptibility to energy deprivation–induced death.
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INTRODUCTION
AMP-activated protein kinase (AMPK) functions as a cellular energy sensor activated by hypoxia, low glucose, and other stressors
that lower ATP levels and raise AMP levels (Hardie et al., 2006;
Shaw, 2006). In response to AMP/ATP ratio–altering events, activated AMPK turns on ATP-generating pathways and inhibits
ATP-consuming pathways, thereby restoring the AMP/ATP ratio
(Williams and Brenman, 2008). AMPK was first discovered as a protein whose activity inhibited preparations of acetyl-CoA carboxylase (ACC1), a regulator of cellular fatty acid synthesis (Winder
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et al., 1997). AMPK is a heterotrimeric protein with a 63-kDa catalytic α subunit and two regulatory β and γ subunits (38 and 36 kDa,
respectively), each of which is encoded by distinct genes (α1, α2;
β1, β2; γ1, γ2, γ3; Davies et al., 1994; Mitchelhill et al., 1994; Gao
et al., 1996; Stapleton et al., 1996; Nielsen et al., 2003), and AMPK
is implicated in a number of signaling pathways (Hardie, 2004,
2007; Shaw, 2009).
Upstream activation of AMPK is mediated by the tumor suppressor liver kinase B1 (LKB1; Shaw et al., 2004) and Ca2+/calmodulin–
dependent kinase kinase β (Hawley et al., 2005; Hurley et al., 2005).
Although LKB1 has clear roles in metabolism, LKB1 is also known as
Par-4 in Caenorhabditis elegans, a key regulator of cell polarity
(Watts et al., 2000; Chartier et al., 2011). Nonetheless, all known
AMPK upstream kinases phosphorylate AMPKα threonine 172
(Thr-172) in the “activation loop” of the catalytic α subunit (both α1
and α2 isoforms), and this phosphorylation event causes >100-fold
increase in kinase activity (Hawley et al., 1996). Conversely, dephosphorylation of Thr-172 by phosphatases can turn AMPK activity off
(Sanders et al., 2007; Rubenstein et al., 2008). In general, mammalian AMPK activity stimulates processes involved in ATP-producing,
catabolic pathways (e.g., increasing the glucose transporter GLUT4
and mitochondrial biogenesis) and inhibits ATP-consuming anabolic
381

pathways (e.g., gluconeogenesis, lipogenesis, and protein synthesis; Hardie and Hawley, 2001; Barnes et al., 2002; Holmes and
Dohm, 2004; Hardie, 2007). The best-defined direct target of AMPK
is the fatty acid synthesis and rate-limiting enzyme ACC, which
AMPK phosphorylates and inhibits to subsequently lower malonylCoA levels and increase fatty acid uptake into mitochondria (Merrill
et al., 1997; Winder et al., 1997; Hardie and Hawley, 2001).
Beyond lipid synthesis, AMPK can also switch off protein synthesis by using two different pathways. These pathways include activation of elongation factor‑2 kinase, which causes inhibition of the
elongation step of translation (Winder et al., 1997; Horman et al.,
2002), and inhibition of the target-of-rapamycin (TOR) pathway,
which stimulates the initiation step of protein synthesis by the phosphorylation of multiple targets (Proud, 2004). TOR is directly activated by an upstream signaling pathway involving the TSC1–TSC2
(tuberous sclerosis complex) heterodimer. AMPK directly phosphorylates TSC2 and thereby activates the TSC (Inoki et al., 2003). There
is also evidence suggesting that AMPK might directly target and
inhibit TOR (Cheng et al., 2004). More recent studies identified
MRLC, raptor, a clock-related gene, and ULK1 as direct targets of
AMPK (Lee et al., 2007; Gwinn et al., 2008; Lamia et al., 2009; Egan
et al., 2011).
In this study, we searched for potential new targets of AMPK activity. From these efforts, we identified nucleoside diphosphate kinase (NDPK) as a potential downstream target of AMPKα. NDPK is
a ubiquitous enzyme that catalyzes the transfer of the γ-phosphate
group from a nucleoside or deoxynucleoside triphosphate (NTP or
dNTP) to a nucleoside or deoxynucleoside diphosphate (NDP or
dNDP, respectively) involving a high-energy phosphoenzyme intermediate (Rosengard et al., 1989; Engel et al., 1995). Functionally,
NDPK maintains pools of nucleoside and deoxynucleoside triphosphates for processes central to energy utilization, for example, DNA
synthesis and translation, using diphosphate substrates (Engel et al.,
1995). In addition, the Drosophila homologue of NDPK is required
in vivo during normal development for guided cell migration
(Rosengard et al., 1989; Randazzo et al., 1991; Dammai et al., 2003;
Nallamothu et al., 2008). Here we suggest mechanisms by which
AMPK normally inhibits NDPK activity through phosphorylation of a
highly conserved serine within NDPK.

RESULTS
Two-dimensional differential in-gel electrophoresis analyses
identify NDPK as a phosphoprotein
The overall goal of our study was the identification of potential new
targets of AMPK—keys for understanding energy homeostasis and
metabolic disease that might be mediated by AMPK signaling.
We performed two-dimensional differential in-gel electrophoresis (2D-DIGE) using cytosolic brain lysates derived from wild-type
(WT) and AMPKα 1/2 double-knockout (KO) mice (Williams et al.,
2011) devoid of all AMPK catalytic activity to identify proteins altered in abundance or posttranslational modification between the
WT and KO. One particular protein spot showed a potential shift in
migration when comparing WT- and KO-derived lysates but a similar
total abundance (Figure 1A).
Given that AMPKα functions as a kinase and the WT spot migrated higher on the gel, this spot might contain a modified protein
that was no longer phosphorylated in the KO and thus would migrate differently. A second 2D-DIGE experiment was performed
with only WT lysate. However, the WT sample was divided into two
samples; the first sample was treated with phosphatase, and the
second sample was untreated. A qualitatively similar result to the
WT/KO 2D-DIGE comparison was observed (Figure 1B).
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FIGURE 1: 2D-DIGE identifies NDPK as a phosphoprotein with
reduced phosphorylation in AMPKα1/2-targeted knockout brain.
(A) 2D-DIGE identifies overlapping/adjacent protein spots with slower
mobility in wild-type (red) compared with AMPKα-knockout (green)
brain. (B) Phosphatase treatment of wild-type extracts (blue) results in
greater mobility compared with untreated samples (magenta). All four
protein spots were identified as NDPK. (C) Although total NDPK
protein levels are similar, immobilized metal ion affinity
chromatography purification of phosphoproteins demonstrates more
phospho-NDPK in wild-type brain.

After performing the 2D-DIGE experiments, all four adjacent
spots of the gel corresponding to the WT or KO spots were excised
and identified. All protein spots were confirmed to be nucleoside
diphosphate kinase A (NDPK-A; EC 2.7.4.6), also known as Nm23
(nonmetastatic 23). Western blotting indicated that there was no
significant difference in NDPK protein expression levels in the total
WT versus KO lysate fractions (Figure 1C, Load, and Supplemental
Figure S1A). However, a difference was noted when phosphoprotein
enrichment was performed prior to Western blot analysis for NDPK,
which indicated more phospho-NDPK exists in WT compared with
KO brain lysate (Figure 1C, Eluate, and Supplemental Figure S1A).

Drosophila NDPK activity is inhibited by AMPK function,
and loss of NDPK function can compensate for loss of
AMPKα function
Although there are multiple genes that encode for NDPK activity in
mammals (Boissan et al., 2009), there is only a single NDPK gene in
Drosophila with previously characterized genetic loss-of-function
mutations available for studies. We therefore used Drosophila genetics and a well-established biochemical NDPK activity assay
(Timmons et al., 1995; Krishnan et al., 2001) to study NDPK activity
in Drosophila. Using two genetically defined null alleles, we demonstrated gene-dosage responsiveness for NDPK activity (Figure 2A).
We subsequently confirmed that the decreased NDPK biochemical
activity also roughly correlated with the NDPK protein levels detected in various genetic NDPK mutant genotypes by Western blot
(Figure 2B and Supplemental Figure S1B).
We next investigated the seemingly inverse relationship between
NDPK and AMPK activities by reducing AMPKα function through
the use of a transgenic RNA interference (RNAi)–based expression
system that phenocopies genetic loss of AMPKα function and only
allows Drosophila development to reach the late pupal/pharate
adult stage without producing eclosing adults (Johnson et al., 2010).
When larvae with decreased AMPKα function, through RNAi (Johnson et al., 2010; Supplemental Figure S2, A and B), were assayed for
NDPK activity, a significant increase was observed (Figure 2C).
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FIGURE 2: NDPK assay activity in Drosophila directly correlates with
NDPK but inversely with AMPKα protein expression levels.
(A) Quantification of the specific activities and (B) protein levels of the
Drosophila NDPK alleles compared with wild-type show NDPK activity
closely tracks NDPK protein levels (n = 5). **p < 0.001 and *p < 0.005
vs. the wild type. (C) The RNAi-mediated reduction of the AMPKα
level in first-instar larvae leads to an increase in NDPK activity (n = 3).
Actin-GAL4 was the driver for the expression of the AMPKα-RNAi
transgenic element, and the RNAi-mediated reduction of AMPKα
protein only occurs when the GAL4 is present. ***p < 0.0005. Data
are shown as mean ± SEM.

Although these results are suggestive that AMPK might inhibit
NDPK activity, because no prior report described the regulation of
NDPK activity by phosphorylation, it was unclear whether loss of
NDPK would enhance or inhibit AMPK genetic function. Initially, we
used the transgenic RNAi-based expression system to reduce
AMPKα function and found that introducing a single NDPK loss-offunction mutation for either NDPK allele (Figure 2B and Supplemental Figure S1B) rescued otherwise lethal AMPKα knockdown animals
to viability/eclosion (Table 1). In addition, heterozygous NDPK lossof-function alleles were able to rescue previously published (Mirouse
et al., 2007) null AMPKα lethal loss-of-function alleles to viability as
well, an effect otherwise only seen by dominant-negative S6 kinase,
which is known to antagonize AMPK function (Montagne et al.,
1999). In support of these results, increased NDPK expression did
not rescue AMPKα knockdown or loss-of-function animals but instead made the transgenic animals susceptible to energetic stress
by accelerating starvation-induced death in a defined starvation
paradigm (Johnson et al., 2010; Figure 3).

AMPK directly inhibits NDPK activity through
phosphorylation
The preceding results suggested that AMPK and NDPK genetically
antagonize each other. Combination of these genetic results with
the biochemical identification of decreased NDPK phosphorylation
Volume 23 January 15, 2012

AMPKα loss-offunction allele
2 rescue (number rescued/
total scored)

UAS-S6k (DN)

Yes (11)

Yes (14/130)

Yes (23/122)

UAS-TOR
(DN)

Yes (13)

No (0/68)

No (0/42)

NDPK1

Yes (26)

Yes (7/91)

Yes (12/96)

NDPK2

Yes (41)

Yes (5/101)

Yes (8/71)

UAS-AMPKα

Yes (100)

Yes (22/65)

Yes (36/75)

UAS-AMPKγ

No

No (0/63)

No (0/94)

UAS-GFP

No

No (0/52)

No (0/77)

2

NDPK
tubulin
ty
pe

B

AMPKα
Transgene or RNAi
loss-of-funcrescue (%
tion mutation expected)

AMPKα lossof-function
allele 1 rescue (number
rescued/total
scored)

TABLE 1: AMPKα RNAi and AMPKα loss-of-function rescue by NDPK.

in AMPKα mutant brain suggests a potential model by which AMPK
directly phosphorylates NDPK to inhibit NDPK function. The relationship between NDPK and AMPK was subsequently investigated
in vitro using AMPK purified from a cell expression system (Dyck
et al., 1996), which was subsequently added to NDPK protein. When
these protein complexes were incubated together before performing NDPK assays, NDPK activity was significantly decreased and
substantially further decreased upon additional AMPK activation
(Figure 4A and Supplemental Figure S1C) with cobalt chloride (Lee
et al., 2003; Supplemental Figure S3; CoCl2 treatment was the most
effective AMPK activator of those tested), which demonstrates
AMPK activity inhibits NDPK activity in vitro (Figure 4B).
After establishing that AMPK can directly phosphorylate NDPK
in vitro, we identified potential NDPK phosphorylation sites in vivo.
The protein spot corresponding to NDPK from WT mouse brain was
excised for phosphopeptide mapping (Yale Mass Spectrometry
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FIGURE 3: NDPK transgenic overexpression in Drosophila leads to
decreased survival under starvation conditions. Male flies (n = 30)
were starved in empty food vials containing filter paper saturated
with deionized H2O. Tubulin-GAL4 was the driver for overexpression
of the NDPK transgenic element, and NDPK protein overexpression
only occurs when the GAL4 element is present. Asterisk denotes
statistically different values; for the 60-, 72-, 84-, and 96-h time points,
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Supplemental Figure S4). A single peptide (Figure 5A, underlined
red) with three candidate serines was found to contain a single
phosphoserine. Of importance, this sequence flanked the catalytic
NDPK histidine residue and contained three total serine residues,
only two of which were conserved from Drosophila to human.
To identify which serine residues may be phosphorylated by
AMPK, the two conserved serine residues were mutated singly for in
vitro AMPK phosphorylation/NDPK activity assays. Single mutations
of either serine (S120 or S125) to alanine in NDPK had no significant
effect on NDPK activity. Similarly, mutating S125 to the phosphomimetic amino acid glutamate also had no effect on NDPK activity
(Figure 5B). However, mutating S120 to glutamate (E) resulted in
insoluble protein under native protein purification conditions. In addition, when solubilized under denaturing/renaturation conditions,
the S120E mutant protein was inactive even when WT NDPK that
underwent the same treatment maintained significant activity (Supplemental Figure S5). We therefore added purified AMPK to purified NDPK protein—either WT or with the serine-to-alanine mutations to measure AMPK-mediated inhibition of NDPK activity.
Indeed, adding the AMPK complex to S125A decreased NDPK activity; however, adding AMPK to S120A had no inhibitory effect on
NDPK activity, suggesting that S120 is a residue that can be phosphorylated to inhibit NDPK activity (Figure 5B).
To determine whether AMPK could phosphorylate NDPK, in vitro
kinase assays were performed to monitor the incorporation of 32P
into a modified version of the NDPK phosphopeptide (the NDPKtide, with all serines except S120 mutated to alanine; Figure 5A and
Supplemental Figure S6) versus the SAMS peptide, a specific, wellestablished gold standard substrate for AMPK activity (Davies et al.,
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FIGURE 5: An identified in vivo phospho-NDPK peptide and
identification of an AMPK-dependent NDPK phosphoserine inhibitory
site. (A) Sequence alignment of the active-site region of NDPK (purple
shading) and identified NDPK phosphopeptide (red underline). The
active-site histidine and conserved serines (Ser-120 and Ser-125) are
highlighted in green, red, and blue, respectively. (B) The specific
activities of wild-type and each NDPK mutant with (dark-colored
columns) and without (light-colored columns) the addition of activated
AMPK. The decrease in activity for the S120A mutant protein was not
statistically significant (p = 0.36, n = 3). *p < 0.05, n = 3. Data are
shown as mean ± SEM.

1989). The kinase assays revealed very similar calculated specific
activities for the SAMS and the NDPKtide peptides, Vmax = 1.47 and
1.29 nmol min−1 mg−1, respectively, with the SAMS peptide being
only a slightly better—but statistically insignificant—substrate
(Figure 6, A and B, and Supplemental Figure S7).

DISCUSSION
Elaborating targets for the cellular energy sensor AMPK is key for
understanding the roles this molecule plays in energy homeostasis
and metabolic disease. Through the use of proteomic techniques,
we were able to identify proteins that are potentially regulated and/
or phosphorylated by AMPK and further prioritize these proteins for
study based on genetic evaluation in Drosophila. On the basis of
these criteria and studies, the protein NDPK was identified as a
good candidate for additional study.
Phosphopeptide mapping identified a peptide (Figure 5A, underlined in red) that contained a phosphorylated serine residue. Mutagenesis studies performed on the two conserved serine residues
indicated that S120 is the critical residue for NDPK regulation
(Figure 5B), which has been a speculated but, up to this point, not
experimentally validated mechanism for NDPK regulation
(Venerando et al., 2011). These results correlate well with previous
studies indicating that NDPK is phosphorylated at serine residue(s)
Molecular Biology of the Cell
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(WT) myc-tagged AMPK. A synthesized NDPK peptide (containing
only one serine, Ser-120) and the SAMS peptide were compared as
AMPK substrates (n = 3). (B) Kinase assays were performed with
varying amounts of the substrate peptide and WT-AMPK to measure
the kinetics of the SAMS and NDPK peptides (n = 3).

(MacDonald et al., 1993; Almaula et al., 1995; Treharne et al., 2009).
In fact, two prior studies, one in Escherichia coli (Almaula et al.,
1995) and a proteome-wide phospho-mapping study in Drosophila
(Zhai et al., 2008), found this serine (S120) to be a candidate for
phosphorylation. In addition, in vitro assays mixing protein kinase
CK2 (CK2; formerly casein kinase 2) with NDPK demonstrated that
serine phosphorylation of NDPK may be a mechanism to negatively
regulate its activity (Biondi et al., 1996) and indicate that the serine
phosphorylation of NDPK may inhibit NDPK’s phosphotransferase
function (Treharne et al., 2009), which are in agreement with our results. Therefore, NDPK activity, which normally has a high turnover
rate, might be partially inhibited by serine phosphorylation (Biondi
et al., 1996). Conversely, the need for large amounts of NTPs could
be satisfied rapidly via phosphatase-catalyzed dephosphorylation of
NDPK, thus increasing NDPK activity (Biondi et al., 1996). However,
until now, the mechanistic details of NDPK inhibition due to a specific phosphorylation event in vivo have been unclear.
The critical serine identified in this work, S120, is strictly conserved in all prokaryotic and eukaryotic NDP kinases and has been
linked to a direct involvement in the catalytic mechanism of stabilizing the NDPK catalytic site (His-118) through site-directed mutagenesis and crystal structure studies (Tepper et al., 1994; Giraud et al.,
2006). A serine 120-to-glycine (S120G) mutation of nm23-H1 (NDPKA) was even identified in several aggressive neuroblastomas (Chang
et al., 1994). Of interest, biochemical studies indicated that this mutant S120G was still active, which is comparable to our results with
our S120 mutants (Chang et al., 1994; Freije et al., 1997).
We verified serine 120 as a residue capable of being phosphorylated by AMPK through the use of in vitro kinase assays and comparisons to the SAMS peptide, which is a specific substrate for
Volume 23 January 15, 2012

AMPK that contains the optimal AMPK-binding sequence (Gwinn
et al., 2008). Although the NDPKtide does not contain the described
optimal AMPK-binding sequence, several described AMPK substrates also do not contain this sequence, including histone H2B,
myosin light chain, the tumor suppressor p53, and the cyclin-dependent kinase inhibitor p27 (Jones et al., 2005; Lee et al., 2007; Liang
et al., 2007; Bjorklund et al., 2010; Bungard et al., 2010; Kim et al.,
2011). Of importance, the NDPK peptide displayed kinetic characteristics similar to those of the SAMS peptide (Figure 6B), and these
kinetic characteristics were completely abolished when S120 was
individually mutated to an alanine (Supplementary Figure S7). Thus
the NDPKtide sequence and serine 120 are a specific peptide region and residue targeted by AMPK for phosphorylation.
Although many studies have suggested phosphorylation may affect NDPK activity, a clear genetic link to a kinase in vivo has been
missing to this point. A previous study (Treharne et al., 2009) provided 1) biochemical evidence to indicate a direct interaction between AMPK and NDPK, although other groups have been unable
to reproduce these results (Annesley et al., 2011), and 2) data suggesting that AMPK activity decreases NDPK’s phosphotransferase
activity through the phosphorylation of NDPK serine residues, but
was unable to mechanistically define the interaction and indicated
that the AMPK/NDPK interaction may still be indirect. Other studies
investigating the AMPK/NDPK interaction have also served to confound this interaction—see, for example, the retractions of several
papers that had sought to directly address this interaction biochemically (Crawford et al., 2005, 2006a, 2006b, 2007). Nevertheless,
these retracted papers claimed that NDPK regulated and activated
AMPK, which is not the regulatory interaction we describe here.
In our proposed model, active NDPK helps produce nucleotides
for various anabolic pathways in the presence of inactive AMPK, that
is, a high-energy and/or low-stress cellular state (Figure 7A). However,
when cellular ATP falls and AMP levels rise, AMPK is activated and
phosphorylates the critical serine 120 residue of NDPK to decrease its
activity and, thereby, save ATP stores (Figure 7B). Thus AMPK is able
to fulfill its primary energy gauge function and balance the formation
of nucleotides with the conservation of ATP under energetic stress.
Such a model might also explain why a mutation of this critical serine
to a nonphosphorylatable glycine residue would lead to more aggressive neuroblastomas (Chang et al., 1994); tumors could synthesize deoxynucleotides for DNA replication and use the increased
biosynthetic products of NDPK for elevated levels of glycolysis (Green
et al., 2011) even during energetic stress if this “off switch” was absent. This paradigm illustrates a potential direct link between tumor
suppression and control of cellular metabolism. In addition, the activation of NDPK would also trigger an increase in the ADP/ATP ratio,
which would further enhance AMPK activity by protecting AMPK from
dephosphorylation. Neuroblastomas with the NDPK S120G mutation
would then have elevated AMPK activities, as well as constitutive
NDPK activation, which might increase glucose uptake/oxidation and
help with tumor survival. Thus this AMPK-mediated NDPK inhibitory
function is consistent with numerous studies suggesting that AMPK,
as a molecule downstream of the human tumor suppressor LKB1, has
tumor-suppressive activities (Jones et al., 2005; Shackelford and
Shaw, 2009). Of course, it is unlikely that AMPK activity is the only
activity capable of regulating NDPK activity; however, in brain lysates,
it appears that AMPK activity is a major one.

MATERIALS AND METHODS
Materials
All chemicals were of an analytical grade and, unless otherwise
noted, from Sigma-Chemical (St. Louis, MO) or Fisher Scientific (Fair
AMPK directly phosphorylates NDPK
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decreased biochemical activities.

Carolina–Chapel Hill and in accordance with National Institutes of
Health guidelines.
For the preparation of brain lysate, a whole mouse brain (375–
425 mg) was processed in 10 ml of ice-cold lysis buffer A (50 mM
Tris-HCl, pH 7.5, protease [P2714; Sigma-Aldrich] and phosphatase
[P5726; Sigma-Aldrich] inhibitor cocktails [note: for the preparation
of the phosphatase-treated WT brain lysate for 2D-DIGE, the phosphatase inhibitor cocktail was omitted for 2.5 U/ml alkaline phosphatase (final concentration; P6774; Sigma) and the sample was incubated for 1 h with the addition of 1 mM MgCl2 (37°C) before the
high-speed centrifugation step], and benzonase nuclease) using a
Tissuemiser homogenizer (Fisher Scientific). The lysate was centrifuged at 1000 × g for 20 min (4°C). The supernatant was then centrifuged for a second time. The resultant clarified supernatant was
centrifuged at 100,000 × g to produce the cytosol. The pellet was
discarded, and the supernatant (cytosol) was directly used for Western blotting and then for 2D-DIGE analyses after it was cleaned using a 2D Clean-Up Kit (GE Healthcare, Piscataway, NJ).

2D-DIGE protocols and protein identifications
The 2D-DIGE experiments were performed by the University of
North Carolina Systems-Proteomics Center using previously described methodologies (Osorio et al., 2007). Protein spot identification was performed by the Yale Mass Spectrometry and Proteomics
Resource Core (New Haven, CT) using peptide mass fingerprinting
tandem mass spectrometry data, as previously described (Osorio
et al., 2007; Pinaud et al., 2008).

Purification of phosphoproteins by immobilized metal
affinity chromatography
Phosphoproteins were purified from mouse brain lysates using a
PhosphoProtein Kit (Qiagen, Valencia, CA), as described by the
manufacturer. The brain lysates were prepared as described; however, 0.25% 3-([3-cholamidopropyl]dimethyl-ammonio)-1-propanesulfonate was included in the buffer and throughout the purification
process, as recommended by the manufacturer’s protocol.

Plasmid construction
Lawn, NJ). [γ-32P]ATP (specific activity 3000 Ci/mmol) was from
PerkinElmer (Boston, MA). The SAMS (HMRSAMSGLHLVKRR) and
NDPK (RNIIHGSDAVKAKRR) peptides were synthesized by Abgent
(San Diego, CA) and the University of North Carolina Microprotein
Sequencing and Peptide Synthesis Facility (Chapel Hill, NC), respectively. The hemagglutinin (HA)-tagged human AMPKγ1 and rat
AMPKβ1 constructs were gifts from R. Shaw. Glutathione S-transferase (GST)–tagged AMPKα1 was a gift from L. Witters. The antibodies used were as follows: anti-NDPK (C-20, sc-343; Santa Cruz
Biotechnology, Santa Cruz, CA), anti–phospho-AMPKα (40H9) and
anti-AMPKα (23A3; Cell Signaling, Beverly, MA), and anti–α-tubulin
(clone B-5-1-2; Sigma-Aldrich). Anti-dNDPK (reactive to protein of
Drosophila origin, dNDPK) was a gift from T. Hsu.

Transgenic animals and brain sample/lysate preparation
Three-month-old male mice were killed to obtain brain tissue
(kindly provided by T. Williams, University of North Carolina). The
genotypes used were as follows: wild type, human glial fibrillary
acidic protein-Cre (hGFAP-Cre) mice (K. McCarthy, University of
North Carolina), and conditional AMPKα 1/2 knockout mice
(Williams et al., 2011) to produce AMPKα1−/−α2F/F-hGFAP-Cre
mice. The animals were handled under protocols approved by the
Institutional Animal Care and Use Committee (Institutional Animal
Care and Use Committee ID 09-149.0) of the University of North
386 | R. U. Onyenwoke et al.

A pET21b (Novagen, Gibbstown, NJ) construct containing the
cDNA for wild-type NDP kinase A, inserted in the BamHI-NdeI site,
was obtained from M.-L. Lacombe. The NDPK gene was PCR amplified from this construct using the primer pair F, 5′-AAAGGATCCGGCCAACTGTGAGCGTACCTTC-3′, and R, 5′-AAAGGATCCGGCCAACTGTGAGCGTACCTTC-3′), digested with BamHI and SalI,
and ligated into a pET28b (Novagen) vector cut with the same restriction enzymes for expression as a histidine (His)-tagged protein.
Site-directed mutagenesis of NDPK was carried out using bridging PCR. The primer pairs for the construction of each NDPK variant
are as follows: S120E (F, 5′-ATTATACATGGCGAGGATTCTGTGGAGAGTGC-3′; R, 5′-TCCACAGAATCCTCGCCATGTATAATGTTCCTG-3′), S125E (F, 5′-TTCTGTGGAGGAGGCAGAGAAGGAGATCGG-3′, R, 5′-CCTTCTCTGCCTCCTCCACAGAATCACTGCC-3′),
S120A (F, 5′-ATTATACATGGCGCTGATTCTGTGGAGAGTGC-3′, R,
5′-TCCACAGAATCAGCGCCATGTATAATGTTCCTG-3′), and S125A
(F, 5′-TTCTGTGGAGGCTGCAGAGAAGGAG-ATCGG-3′, R, 5′CCTTCTCTGCAGCCTCCACAGAATCACTGCC-3′).

Purification of NDP kinase
Full-length His-tagged wild-type and mutant proteins were expressed in high yields using E. coli BL21-Gold (DE3) pLysS competent cells (Agilent Technologies, Palo Alto, CA) transformed with
the appropriate construct using heat shock, as described by the
Molecular Biology of the Cell

manufacturer, and purified using batch/gravity-flow column purification with Talon IMAC resin (Clontech, Mountain View, CA) under
native conditions (denaturing conditions, i.e., 4 M urea, were used
throughout the purification process for the S120E mutant) following
the manufacturer’s instructions.

Cell culture and AMPKα/β/γ coimmunoprecipitation
For mammalian cell expression of AMPK, the AMPK subunits were
used as previously described (Dyck et al., 1996). HEK293 cells were
cultured in complete DMEM (Life Technologies, Carlsbad, CA) containing 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville,
GA) at 37°C in 5% CO2. For the transient expression of AMPK protein, the cells were plated 24 h before the experiments in 15-cm
dishes and then transfected with the three plasmids using Lipofectamine 2000 (1 μg DNA per 2 μl; Invitrogen, Carlsbad, CA) following the manufacturer’s protocols. Note: For some kinase assays,
GST-AMPKα1 was replaced with WT or kinase-dead [KD] myc-AMPK
(in a pCMV-myc vector; Clontech; Kazgan et al., 2010).
After 24 h, fresh medium containing CoCl2 (200 μM) was added
to the cells for 1 h in the incubator to activate AMPK, as previously
described (Lee et al., 2003). Cells were then harvested, lysed in
0.5 ml of lysis buffer A plus 1.0% Triton X-100 with shaking for 1 h
(4°C), and centrifuged at 16,000 × g for 10 min (4°C). GST- and myctagged AMPK were purified from the supernatants via GST pulldown, using glutathione Sepharose 4B (Amersham, GE Healthcare),
and immunoprecipitation performed, using anti–c-Myc antibody
(9E10; Developmental Studies Hybridoma Bank, University of Iowa,
Iowa City, IA) at a 1:100 dilution for 1 mg/ml lysate and A/G agarose
(Pierce Protein Research Products, Rockford, IL), respectively, according to the manufacturer’s instructions and as previously described (Kazgan et al., 2010). Washed, bead-adsorbed GST-AMPK
was used for NDPK assays, as previously described (Dyck et al.,
1996), and both GST- and myc-tagged AMPK were used for kinase
assays.

NDPK assays
A well-known procedure to assay NDP kinase activities was used
(Timmons et al., 1993; Krishnan et al., 2001). In brief, 10 μl of diluted
enzyme (lysate or purified NDPK; see further discussion) was added
to a 990-ml reaction mixture containing 100 mM Tris-HCl, pH 7.5,
10 mM MgCl2, 100 mM KCl, 0.4 mM NADH, 6 mM ATP, 0.7 mM
TDP, 4 mM phosphoenolpyruvate (PEP), and 10 U of pyruvate kinase
and lactate dehydrogenase each. The absorbance of NADH at
340 nm was then recorded. A unit of activity is defined as the amount
required to convert 1 μmol of NADH to NAD+ in 1 min.
For NDPK assays with flies or fly larvae, 20 adult flies or 40–50 fly
larvae were homogenized in 50 μl of ice-cold buffer (100 mM TrisHCl, pH 7.5, 10 mM MgCl2, and 100 mM KCl). The lysates were
centrifuged at 10,000 × g for 10 min (4°C). The clarified supernatant
was then diluted 1:10 for inclusion in the described assay (0.5–2 μg
of protein used). Purified NDPK was purchased from Sigma-Aldrich
(N2635) and also produced as purified His-tagged versions and
used at amounts of 10–50 and 50–200 ng, respectively, in NDPK
assays. For the inhibition assays including AMPK, 3 μg of bead-adsorbed GST-AMPK was incubated with purified NDPK or purified
His-tagged NDPK at room temperature for 2 h before executing the
NDPK assays.

Kinase assays
Kinase assays were performed according to previously described
methods (Davies et al., 1989). Briefly, AMPK activity assays with GSTAMPK were performed at room temperature (25°C) in a 25-μl reacVolume 23 January 15, 2012

tion mixture containing 3–12 μg of protein in kinase buffer (50 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.0, 75 mM
NaCl, 5 mM sodium acetate, 5 mM magnesium chloride, 1 mM dithiothreitol, 8% glycerol, 0.1 mM EDTA, 200 μM AMP and ATP, and
2 μCi of [γ-32P]ATP) with or without the SAMS or NDPK peptide. After a 30-min incubation period, the reaction mixtures were counted
in a scintillation counter. Kinase assays with myc-tagged KD-AMPK
and myc-tagged WT-AMPK were performed in the same manner as
described earlier, but 0.5 μg of protein was added to the reaction
mixture. AMPK activity is expressed as picomoles of 32P incorporation into the peptide per minute per microgram of protein.

Western blotting
Fly protein lysates for immunoblotting were prepared by collecting
equal numbers of male and female flies (50 total) of each genotype
in a 1.5-ml microfuge tube. One milliliter of lysis buffer A was added
to each sample. Flies were then ground to homogeneity, incubated
for 1 h with shaking (4°C), and centrifuged at 16,000 × g for 10 min
(4°C). Supernatants were collected, and protein concentrations were
determined using the Bio-Rad DC protein assay (Richmond, CA).
Note: The preparation of brain lysate samples was described earlier.
Proteins (50 μg) were then boiled in loading buffer and subjected
to SDS–PAGE (Invitrogen), followed by Western analyses using
1:1000 dilutions of all primary antibodies, with the exception of
anti–α tubulin (1:16,000). Secondary antibodies (IRDye infrared antibodies; LI-COR Biosciences, Lincoln, NE) were used at a dilution of
1:2000. Scanning, analyzing, and quantification of blots were performed via the Odyssey Infrared Imaging System (LI-COR Biosciences). Three or more independent experiments were performed
for all immunoblotting data.

Fly stocks, crosses, rescue experiments, and lifespan
measurements
Drosophila melanogaster strains obtained from the Bloomington
Stock Center (Bloomington, IN) included the following: Act-GAL4,
tub-GAL4, awdKRS6 (referred to as NDPK1 in this study), awdMSM95
(NDPK2), UAS-AMPKαRNAI, the SNF1A1 and SNF1A3 mutants, UASSNF1A, UAS-S6k.KQ, UAS-Tor.TED, and UAS-GFP. UAS-SNF4 and
UAS-NDPK were gifts from D. Kretzschmar and T. Hsu, respectively.
All flies were maintained at 25°C in yeast-cornmeal vials, and all
crosses were also performed in cornmeal-yeasted vials.
For the AMPKα RNAi rescue experiments, males carrying a
transgene or loss-of-function mutation on the second or third chromosome were mated to virgin females carrying a GAL4 (either
tub-GAL4 or Act-GAL4, respectively). From these crosses, male
progeny carrying the transgene or loss-of-function mutation and
the GAL4 were mated to virgin females carrying UAS-AMPKαRNAI.
The progeny from this second cross were then scored for rescue,
that is, viable adult flies in spite of AMPKα RNAi knockdown.
For the AMPKα loss-of-function rescue experiments, males carrying a transgene or loss-of-function mutation on the second or third
chromosome were mated in parallel to virgin females from both the
SNF1A1 and SNF1A3 loss-of-function lines. The male progeny from
both of these crosses were scored for rescue, that is, viable adult
flies in spite of carrying the lethal loss-of-function mutation/phenotypically, non–bar-eyed males.
Measurements of lifespan have been widely used in Drosophila
as a metric of stress sensitivity (Johnson et al., 2010). Thirty 3- to
5-d-old male flies were starved in empty food vials that contained
pieces of filter paper saturated with deionized H2O. We assessed
the percentage survival of at least three replicate vials three times
daily.
AMPK directly phosphorylates NDPK
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Statistical analyses
Comparisons were made using the unpaired Student’s t test with
p < 0.05 considered significant. Values are presented as the mean ±
the SE of the mean (SEM) and are represented as error bars. Indirect
immunofluorescent detection of a secondary antibody (LI-COR
Biosciences) was scanned and standardized to an internal standard
to calculate and quantify arbitrary units using the Odyssey Infrared
Imaging System, and a representative Western blot is shown in each
figure.
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